“…Immune modulation can thus be uncoupled from bacterial replication during acute infection. Brucella-targeting SLAMF1 may have broader consequences given that, on the one hand, Brucella colonising and persisting in murine bone marrow (Gutierrez-Jimenez et al, 2018) is transmitted by bone marrow transplantation in humans (Naparstek, Block, & Slavin, 1982;Tuon, Gondolfo, & Cerchiari, 2017), and on the other hand, SLAMF1 is a key cell surface receptor of haematopoietic stem cells (Oguro, Ding, & Morrison, 2013 Des Services Vétérinaires des Bouches du Rhône and the Regional Ethic Committee (authorization number 13.118). Authorisation of Brucella experimentation in BSL3 facility was given under the numbers: AMO-076712016-5, AMO-076712016-6, and AMO-076712016-7.…”